|Day Low/High||10.19 / 10.51|
|52 Wk Low/High||9.70 / 35.34|
Endo International slipped 5% ahead of market's open Friday.
An FDA advisory committee has found that risks of Endo International's pain drug Opana ER now overshadow the drug's benefits.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International plc (NASDAQ:ENDP) securities...
The share prices of Mylan, Sears and Endo International fell dramatically in 2016, and the companies face significant challenges ahead.
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.
There are more dogs on the S&P 500 than on the Dow. Here's one example.
Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 6, 2017 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased or otherwise acquired...
Impax Laboratories CEO G. Frederick Wilkinson steps down amid a Department of Justice generic price-fixing investigation. J. Kevin Buchi, who joined the board last month, was tapped as interim CEO.
Shares of leading generics fall as more charges are expected.
Endo Returns Rights for BELBUCA™ to BDSI and Eliminates Pain Sales Field Force, Directing Greater Focus and Resources on the Specialty Branded Business
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...